SBH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Sally Beauty Holdings Inc (SBH) is not a strong buy for a beginner, long-term investor at this moment. While the stock shows some positive technical indicators and analyst upgrades, the financial performance and lack of significant catalysts suggest a cautious approach. Given the investor's preference for long-term growth, it is better to wait for more robust financial improvement or stronger growth signals before investing.
The technical indicators show a bullish trend with MACD positively expanding, RSI in the neutral zone, and moving averages aligned bullishly (SMA_5 > SMA_20 > SMA_200). The pre-market price of $16.6 is near the R1 resistance level of $16.613, indicating limited immediate upside potential.
Analysts have raised price targets recently, with TD Cowen and Canaccord maintaining Buy ratings and projecting upside to $
Gross margin improvement in Q1 2026 (+0.79% YoY) indicates operational efficiency.
SwingMax sent an entry signal on 2026-02-03, with a modest 0.82% price gain since then.
Q1 2026 financials show declining net income (-25.33% YoY) and EPS (-22.41% YoY), which are concerning for long-term growth.
The stock trend analysis predicts a potential decline of -0.96% in the next day, -2.22% in the next week, and -3.26% in the next month.
Lack of significant trading activity from hedge funds, insiders, or influential figures.
In Q1 2026, revenue grew slightly by 0.56% YoY to $943.17M, but net income dropped significantly by -25.33% YoY to $45.56M. EPS also fell by -22.41% YoY to $0.45. Gross margin improved slightly to 51.24%, up 0.79% YoY.
Analysts are mixed on SBH. TD Cowen and Canaccord maintain Buy ratings with price targets of $20, citing durable margins and growth-driving initiatives. However, Morgan Stanley maintains an Underweight rating with a $16 target, citing limited medium-term EBIT growth. Overall, analysts show cautious optimism.
